Last10K.com

Essa Pharma Inc. (EPIX) SEC Filing 6-K Foreign Issuer report for the period ending Monday, October 7, 2019

Essa Pharma Inc.

HISTORY TOOLS
CIK: 1633932 Ticker: EPIX

View differences made from one to another to evaluate Essa Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Essa Pharma Inc..

Continue

Assess how Essa Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Essa Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Essa Pharma Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: News Release Dated October 7, 2019
Ticker: EPIX
CIK: 1633932
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001279569-19-002063
Submitted to the SEC: Mon Oct 07 2019 3:18:41 PM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Monday, October 7, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/epix/0001279569-19-002063.htm